UnknownNot Applicable

NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction

Israel100 participantsStarted 2017-09-15

Plain-language summary

The aim of this study is to investigate the association between NGAL plasma levels in ST-elevation myocardial infarction and the no-reflow phenomenon, adverse events during hospitalization and at 30-day follow-up.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients \> 18 years old presenting with ST-elevation myocardial infarction and undergoing urgent coronary angiography with or without PCI. * Signed informed consent to participate in the study. Exclusion Criteria: * Inability to sign written informed consent. * Chronic renal failure (eGFR \< 30 ml/min/1.73m2).

What they're measuring

No-reflow phenomenon after STEMI

Timeframe: During hospitalization

Trial details

NCT IDNCT03264859

SponsorSheba Medical Center

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2018-10-31

Contact for this trial

Fernando Chernomordik, M.D.

+972-3-5302504 fernando.chernomordik@sheba.health.gov.il

View on ClinicalTrials.gov More No-Reflow Phenomenon trials